Chapman Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,570
Closed -$207K 33
2024
Q1
$207K Buy
+1,570
New +$194K 0.15% 32
2023
Q2
Sell
-1,920
Closed -$204K 37
2023
Q1
$204K Sell
1,920
-1,056
-35% -$114K 0.17% 36
2022
Q4
$330K Hold
2,976
0.3% 32
2022
Q3
$256K Sell
2,976
-150
-5% -$13.4K 0.19% 37
2022
Q2
$285K Hold
3,126
0.2% 39
2022
Q1
$256K Sell
3,126
-4,861
-61% -$383K 0.14% 41
2021
Q4
$612K Sell
7,987
-3,124
-28% -$249K 0.28% 40
2021
Q3
$835K Buy
11,111
+700
+7% +$53.2K 0.43% 31
2021
Q2
$810K Buy
10,411
+650
+7% +$48.3K 0.45% 30
2021
Q1
$718K Hold
9,761
0.45% 29
2020
Q4
$762K Buy
9,761
+1,063
+12% +$81.3K 0.5% 28
2020
Q3
$688K Buy
+8,698
New +$681K 0.51% 31

Other funds holding MRK

Chapman Investment Management's MRK Position: Q2 2024 in Review

Chapman Investment Management sold out of Merck (MRK) in Q2 2024, closing a stake of 1,570 shares — an estimated $207K sold.

Chapman Investment Management first reported a position in MRK in Q3 2020 and held it in 12 quarters. The position peaked at $835K in Q3 2021. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • Chapman Investment Management reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • Chapman Investment Management sold 1,570 Merck shares in Q2 2024, an estimated $207K.
  • Chapman Investment Management first reported a position in Merck in Q3 2020 and held it in 12 quarters.
  • Chapman Investment Management's Merck position peaked at $835K in Q3 2021.
  • 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Chapman Investment Management's 13F filing for Q2 2024, filed 7 Aug 2024.